RP11-434D9.1

Gene basic information

SymbolRP11-434D9.1
Tissuebreast,
Cancertriple negative breast cancer,


Description

LncRNA RP11-434D9.1 is down-regulated in triple negative breast cancer (TNBC) and correlated with TNBC occurrence. Besides, it can be a potential biomarker to differentiate TNBC from non-TNBC (1).


Cancer related information

download as excel csv txt

LncRNA tissue cancer type expression level oncogene/suppress gene pathway binding gene/factor associated gene/factor proliferation apoptosis migration EMT invasion metastasis prognosis tag PMID
0 RP11-434D9.1 breast triple negative breast cancer down / 26910840

Expression profile

adipose adrenal brain breast colon heart kidney leukocyte liver lung lymph node ovary prostate skeletal muscle testis thyroid tissue 0 1 2 3 4 5 6 7 8 fpkm 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 RP11-434D9.1

Expression profile in human body map

TCGA-BLCA TCGA-BRCA TCGA-CESC TCGA-HNSC TCGA-KICH TCGA-KIRC TCGA-KIRP TCGA-LIHC TCGA-LUAD TCGA-LUSC TCGA-PRAD TCGA-STAD TCGA-THCA TCGA-UCEC tissue 0.0 0.5 1.0 1.5 2.0 2.5 3.0 fpkm RP11-434D9.1 type normal tumor

Expression profile in TCGA


Genomic feature visualization


Sequence

Literature

[1]. Lv M, Xu P, Wu Y, Huang L, Li W, et al. (2016). LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Oncotarget 7(11): 13047-59. link pubmed



© Bioinformatics Group of XTBG